MN

Monika Nikhil Vankhedekar

Active Director Director DIN 10349224
DIN 10349224 First appointment Oct 2023 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Monika Nikhil Vankhedekar

Data last updated:

Monika Nikhil Vankhedekar is a Director at Meditune Medexim Private Limited (since 2023). The company operates in Non-Profit Organizations.

DIN 10349224
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 23 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meditune Medexim Private Limited U85300PN2022PTC216344
Director23 Oct 20232022Active

Board colleagues of Monika Nikhil Vankhedekar

Directorship timeline

Open interactive timeline →
Meditune Medexim Private Limited
Premium access

Shareholding and investment profile for Monika Nikhil Vankhedekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Monika Nikhil Vankhedekar

Monika Nikhil Vankhedekar currently holds 1 directorship: Meditune Medexim Private Limited (Director, since 23 Oct 2023).

Monika Nikhil Vankhedekar was first appointed on 23 Oct 2023 as Director at Meditune Medexim Private Limited.

The current boards of Monika Nikhil Vankhedekar's companies include Netra Niraj Dharme (Meditune Medexim Private Limited), Vinod Mohanlalji Chandak (Meditune Medexim Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available